PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-21

Date Title Company
21-Nov-2024 Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 AccessWire
21-Nov-2024 APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived APONTIS PHARMA AG
21-Nov-2024 Panthera Biopartners now offers the broadest range of clinical trial therapy areas of any site management organisation in the UK Panthera Biopartners
21-Nov-2024 Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans Vicebio
21-Nov-2024 NHS Trust’s missed opportunities to treat elderly woman’s pressure sore contributed to permanent nursing home move England’s Health Ombudsman
21-Nov-2024 First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach Pentixapharm Holding AG
21-Nov-2024 RNAConnect Partners With Bioz to Elevate Research Visibility AccessWire
21-Nov-2024 EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%. MPH Health Care AG
21-Nov-2024 NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus
21-Nov-2024 Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG